Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: Hyperkalemia is a potentially life-threatening condition that is common in kidney disease patients. Insulin is used to treat hyperkalemia, but may cause hypoglycemia, especially in kidney disease when insulin may be metabolized more slowly. Objective: We compared the rates of hypoglycemia in patients with low estimated glomerular filtration rate (eGFR) using high versus low doses of insulin for hyperkalemia to determine if lower doses of insulin would decrease the incidence of hypoglycemia. Methods: This was a retrospective study of hospitalized patients receiving intravenous insulin for hyperkalemia during a 6-month period. Patients with low eGFR were analyzed based on how much insulin they received: high dose (10 units, n = 78) versus low dose (5 units, n = 71). Postdose nadir blood glucose values were examined for up to 8 hours after the dose. The percentage of hypoglycemia (blood glucose ≤70 mg/dl) and a subset of severe hypoglycemia (blood glucose <50 mg/dl) were then reported for each dose group. Results: A total of 149 doses were identified in patients with low eGFR. The rates of hypoglycemia were 16.7% and 19.7% ( P = 0.79), respectively, among high-dose (n = 78) and low-dose (n = 71) groups. Rates of severe hypoglycemia were 8.9% and 7.0%, respectively ( P = 0.90). More than 28% of hypoglycemic episodes with high doses occurred after 4 hours (median = 2.5 hours) compared with 14.3% with low doses (median = 2.38 hours). Conclusion: There was no difference in the rate of hypoglycemia or severe hypoglycemia between high or low doses of insulin in patients with low eGFR. We recommend monitoring up to 6 hours after insulin use in hyperkalemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoglycemia resulting from severe systemic illness (spontaneous hypoglycemia), rather than insulin-induced hypoglycemia, is associated with increased risk of inpatient mortality and complications.1366–1368”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1367]
Citations
Cites
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Einhorn, L. M., Zhan, M., Hsu, V. D., Walker, L. D., Moen, M. F., Seliger, S. L., Weir, M. R., & Fink, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.132 · Cited by 646 · cited 1×
“Patients with chronic kidney disease have demonstrated higher rates of both hyperkalemia and hypoglycemia compared to patients with normal renal function as well as a higher rate of mortality associated with hypoglycemia.(7,8) 607559 AOPXXX10.”
BackgroundSoar, J., Perkins, G. D., Abbas, G., Alfonzo, A., Barelli, A., Bierens, J. J. L. M., Brugger, H., Deakin, C. D., Dunning, J., Georgiou, M., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.015 · Cited by 602
Frequency of hypoglycemia and its significance in chronic kidney disease
Moen, M. F., Zhan, M., Hsu, V. D., Walker, L. D., Einhorn, L. M., Seliger, S. L., & Fink, J. C. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00800209 · Cited by 423 · cited 1×
“Patients with chronic kidney disease have demonstrated higher rates of both hyperkalemia and hypoglycemia compared to patients with normal renal function as well as a higher rate of mortality associated with hypoglycemia.(7,8) 607559 AOPXXX10.”
BackgroundDrug Prescribing in Renal Failure: Dosing Guidelines for Adults.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-502_4 · Cited by 360
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults
Bennett, W. M., Aronoff, G. R., Morrison, G., Golper, T. A., Pulliam, J., Wolfson, M., & Singer, I. (1983) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(83)80060-2 · Cited by 243 · cited 2×
“Dosing references recommend a decrease in the insulin dose by 25% for eGFR between 10 and 50 ml/min and 25% to 50% in patients with eGFR <10 ml/min.(10,11) Patients with low eGFR receiving insulin for hyperkalemia are at particular risk for hypoglycemia as the prolonged effect of insulin may outlast the shorter durati…”
BackgroundAlbuterol and insulin for treatment of hyperkalemia in hemodialysis patients
Allon, M., & Copkney, C. (1990) · Kidney International · doi:10.1038/ki.1990.284 · Cited by 220
Brodovicz, K. G., Mehta, V., Zhang, Q., Zhao, C., Davies, M. J., Chen, J., Radican, L., & Engel, S. S. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.754744 · Cited by 112 · cited 2×
“Hypoglycemia was defined as any BG value ≤70mg/dl and, of these, any BG value <50 mg/dl was further defined as severe hypoglycemia.(6) Estimated GFR was calculated by the laboratory system using the modified MDRD (Modification of Diet in Renal Disease Study) equation and reported on all basic and complete metabolic pa…”
BackgroundMethodKim, H. J. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188917 · Cited by 81
Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals
Lacy, C. F. (2004) · Medical Entomology and Zoology · Cited by 80
Managing diabetes in hemodialysis patients: Observations and recommendations
Shrishrimal, K., Hart, P., & Michota, F. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.09054 · Cited by 78 · cited 1×
“As the estimated glomerular filtration rate (eGFR) falls, the clearance of insulin is decreased, and the therapeutic effect of insulin is prolonged.(9) Dosing references recommend a decrease in the insulin dose by 25% for eGFR between 10 and 50 ml/min and 25% to 50% in patients with eGFR <10 ml/min.”
Background
Research works printed but not linked: 1
- Ngugi NN, 1997, East Afr Med J, 74, 503
Cited by
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
European Resuscitation Council Guidelines 2025 Special Circumstances in Resuscitation
Lott, C., Karageorgos, V., Abelairas‐Gómez, C., Alfonzo, A. V. M., Bierens, J. J. L. M., Cantellow, S., Debaty, G. P., Einav, S., Fischer, M. J., Salvado, V. G., et al. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110753 · Cited by 160
Peacock, W. F., Rafique, Z., Vishnevskii, K. A., Michelson, E. A., Vishneva, Е. A., Zvereva, T. N., Nahra, R., Dao, L., & Miller, J. B. (2020) · Academic Emergency Medicine · doi:10.1111/acem.13954 · Cited by 85
“Previous studies have reported a significant risk of hypoglycemia as a complication of the management of hyperkalemia with insulin.(7,31,32) The numerically higher incidence of hypoglycemia in the SZC arm versus placebo observed in this study is not deemed to represent a difference of clinical significance.”
BackgroundPeacock, W. F., Rafique, Z., Clark, C. L., Singer, A. J., Turner, S. A., Miller, J. B., Char, D. M., Lagina, A. T., Smith, L. M., Blomkalns, A. L., et al. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.09.007 · Cited by 75
“This incidence of hypoglycemia as a complication of hyperkalemia treatment is consistent with other studies (17,18).”
Result
Metadata
- Authors
- Pierce, D. A., Russell, G., & Pirkle, J. L.
- Affiliations
- Augusta University (US)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Pierce, Dwayne A.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2015-09-28
- Volume
- 49
- Issue
- 12
- Pages
- 1322-1326
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2174678985
- Cited by
- 48
- References
- 19
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 8 · 2018: 5 · 2017: 3
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- hypoglycemia, hyperkalemia, insulin, D-glucose, estimated glomerular filtration rate, chronic kidney disease, insulin dose, severe hypoglycemia, blood glucose monitoring, intravenous insulin
- MeSH terms
- Adult, Aged, Blood Glucose, Female, Glomerular Filtration Rate, Glucose, Humans, Hyperkalemia, Hypoglycemia, Insulin, Kidney Failure, Chronic, Male, Middle Aged, Retrospective Studies, Incidence, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia. https://app.cochat.ai/papers/10.1177/1060028015607559
- The paper
- Pierce, D. A., Russell, G., & Pirkle, J. L. (2015). Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia. Annals of Pharmacotherapy. https://doi.org/10.1177/1060028015607559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.